Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000258

Type of data
NGS (Exome, RNA-seq, Target Capture)
Access criteria
Controlled-access (Type I)
Total data volume
286 GB
File formats
  • FASTQ
  • BAM
Research
hum0153
Date published
2020-09-28
Date modified
2020-11-18
DDBJ Search
JGAD000258 (opens in a new tab)
JGA Study
JGAS000177 (opens in a new tab)

Analysis method

WES

Materials and participants
Dedifferentiated liposarcoma (ICD10: C49): 29 cases
- 29 dedifferentiated components, 8 well-differentiated components, and 29 peripheral blood tissues
TSGCT (ICD10: D21): 10 cases
- 10 tumor tissues and 10 non-tumor tissues
  • Health status
    Affected
  • Subject count
    39 (Individual)
Disease
Dedifferentiated liposarcoma (C49)
TSGCT (D21)
Sample description
DNAs extracted from tumor and non-tumor tissues/peripheral blood cells
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V5
SureSelect Human All Exon V5 + lincRNA
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
100 bp
Data use policy
NBDC data sharing policy (JGAP000001)

RNA-seq

Materials and participants
Dedifferentiated liposarcoma (ICD10: C49): 19 cases
- 19 Dedifferentiated components and 7 well-differentiated components
TSGCT (ICD10: D21): 18 cases
- 18 tumor tissues
  • Health status
    Affected
  • Subject count
    37 (Individual)
Disease
Dedifferentiated liposarcoma (C49)
TSGCT (D21)
Sample description
RNAs extracted from tumor tissues
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq RNA Exome
TruSeq Stranded mRNA Library Prep Kit
Fragmentation
Heat treatment
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
126 bp
Data use policy
NBDC data sharing policy (JGAP000001)

Targeted DNA sequencing

Materials and participants
TSGCT (ICD10: D21): 34 cases
- 34 tumor tissues and 34 non-tumorl tissues
  • Health status
    Affected
  • Subject count
    34 (Individual)
Disease
TSGCT (D21)
Sample description
DNAs extracted from tumor and non-tumor tissues
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
exon regions of CBL gene
Reagent kit
TruSeq Nano DNA Library Prep Kit
Fragmentation
N/A
Platform
Illumina MiSeq
Read type
Paired-end
Read length
300 bp
Data use policy
NBDC data sharing policy (JGAP000001)